Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 10/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14152013 | 1.00 | MET (0.38) | METALOX5MAPTFDPSLMNA | |
| SCHEMBL2142251 | 0.96 | MET (0.42) | METALOX5MAPTFDPSLMNA | |
| SCHEMBL1564827 | 0.94 | MET (0.37) | METALOX5MAPTFDPSLMNA | |
| SCHEMBL678510 | 0.92 | MET (0.38) | METALOX5MAPTLMNACA12 | |
| SCHEMBL15772156 | 0.92 | MET (0.38) | METALOX5MAPTLMNACA12 | |
| SCHEMBL1565064 | 0.91 | MET (0.42) | METALOX5MAPTFDPSLMNA | |
| SCHEMBL2140305 | 0.90 | MET (0.38) | METALOX5MAPTLMNACA12 | |
| SCHEMBL1563983 | 0.88 | MET (0.42) | METALOX5MAPTFDPSLMNA | |
| SCHEMBL2136678 | 0.88 | MET (0.38) | METALOX5MAPTLMNACA12 | |
| SCHEMBL1564818 | 0.87 | ALOX5 (0.37) | METALOX5CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2534191-B1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | LATS1, LATS2, LCP1 | MET 3618/4885ALOX5 524/4885MAPT 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.